[1]
L. F. Jarskog, S. Miyamoto, and J. A. Lieberman, ‘Schizophrenia: New Pathological Insights and Therapies’, Annual Review of Medicine, vol. 58, no. 1, pp. 49–61, Feb. 2007, doi: 10.1146/annurev.med.58.060904.084114.
[2]
‘Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents - ScienceDirect’ [Online]. Available: http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0166223611001913?_rdoc=1&_fmt=high&_origin=gateway&_docanchor=&md5=b8429449ccfc9c30159a5f9aeaa92ffb&ccp=y
[3]
‘Advances in the pharmacological treatment of Parkinson’s disease: targeting neurotransmitter systems - ScienceDirect’ [Online]. Available: http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0166223613001148?_rdoc=1&_fmt=high&_origin=gateway&_docanchor=&md5=b8429449ccfc9c30159a5f9aeaa92ffb
[4]
‘Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson’s disease - ScienceDirect’ [Online]. Available: http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0959438807000645?_rdoc=1&_fmt=high&_origin=gateway&_docanchor=&md5=b8429449ccfc9c30159a5f9aeaa92ffb
[5]
C. E. Clarke, ‘Parkinson’s disease’, BMJ, vol. 335, no. 7617, pp. 441–445, Sep. 2007, doi: 10.1136/bmj.39289.437454.AD.
[6]
S. Zhai, A. Tanimura, S. M. Graves, W. Shen, and D. J. Surmeier, ‘Striatal synapses, circuits, and Parkinson’s disease’, Current Opinion in Neurobiology, vol. 48, pp. 9–16, Feb. 2018, doi: 10.1016/j.conb.2017.08.004.
[7]
‘Amyotrophic Lateral Sclerosis — NEJM’. [Online]. Available: http://www.nejm.org.ezproxy.library.qmul.ac.uk/doi/full/10.1056/NEJMra1603471
[8]
‘Endocannabinoid Signaling and Long-Term Synaptic Plasticity - annurev.physiol.010908.163149’. [Online]. Available: http://www.annualreviews.org.ezproxy.library.qmul.ac.uk/doi/pdf/10.1146/annurev.physiol.010908.163149
[9]
‘Endocannabinoid Signaling and Long-Term Synaptic Plasticity - annurev.physiol.010908.163149’. [Online]. Available: http://www.annualreviews.org.ezproxy.library.qmul.ac.uk/doi/pdf/10.1146/annurev.physiol.010908.163149
[10]
‘Multiple Functions of Endocannabinoid Signaling in the Brain | Annual Review of Neuroscience’. [Online]. Available: http://www.annualreviews.org.ezproxy.library.qmul.ac.uk/doi/10.1146/annurev-neuro-062111-150420
[11]
‘Animal models for the study of perinatal hypoxic-ischemic encephalopathy: a critical analysis - ScienceDirect’ [Online]. Available: http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0378378296017732?_rdoc=1&_fmt=high&_origin=gateway&_docanchor=&md5=b8429449ccfc9c30159a5f9aeaa92ffb
[12]
‘Current Perspectives on Traumatic Brain Injury’. [Online]. Available: http://www.asha.org/Articles/Current-Perspectives-on-Traumatic-Brain-Injury/
[13]
‘Animal models for the study of perinatal hypoxic-ischemic encephalopathy: a critical analysis - ScienceDirect’ [Online]. Available: http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0378378296017732?_rdoc=1&_fmt=high&_origin=gateway&_docanchor=&md5=b8429449ccfc9c30159a5f9aeaa92ffb
[14]
‘Therapeutics of Alzheimer’s disease: Past, present and future - ScienceDirect’ [Online]. Available: http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0028390813003195?_rdoc=1&_fmt=high&_origin=gateway&_docanchor=&md5=b8429449ccfc9c30159a5f9aeaa92ffb
[15]
‘A review on Alzheimer’s disease pathophysiology and its management: an update - ScienceDirect’ [Online]. Available: http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S1734114014002886?_rdoc=1&_fmt=high&_origin=gateway&_docanchor=&md5=b8429449ccfc9c30159a5f9aeaa92ffb
[16]
‘Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury | Journal of Neuropathology & Experimental Neurology | Oxford Academic’. [Online]. Available: https://academic-oup-com.ezproxy.library.qmul.ac.uk/jnen/article-lookup/doi/10.1097/NEN.0b013e3181a9d503
[17]
‘10.1038/icb.2014.114 : nature.com search’. [Online]. Available: http://www.nature.com.ezproxy.library.qmul.ac.uk/search?exclude-collections=journals_palgrave%2Clab_animal&include-collections=journals_nature%2Ccrawled_content&order=date_desc&q=10.1038%2Ficb.2014.114&q_match=all&sp-a=sp1001702d&sp-m=0&sp-p-1=phrase&sp-sfvl-field=subject%7Cujournal&sp-x-1=ujournal&submit=go
[18]
A. M. Packer, B. Roska, and M. Häusser, ‘Targeting neurons and photons for optogenetics’, Nature Neuroscience, vol. 16, no. 7, pp. 805–815, Jun. 2013, doi: 10.1038/nn.3427.
[19]
S. Walker, M. Permezel, and S. Berkovic, ‘The management of epilepsy in pregnancy’, BJOG: An International Journal of Obstetrics & Gynaecology, vol. 116, no. 6, pp. 758–767, May 2009, doi: 10.1111/j.1471-0528.2009.02141.x.
[20]
W. Löscher, ‘Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs’, Seizure, vol. 20, no. 5, pp. 359–368, Jun. 2011, doi: 10.1016/j.seizure.2011.01.003.
[21]
S. Yokobori, K. Hosein, S. Burks, I. Sharma, S. Gajavelli, and R. Bullock, ‘Biomarkers for the Clinical Differential Diagnosis in Traumatic Brain Injury-A Systematic Review’, CNS Neuroscience & Therapeutics, vol. 19, no. 8, pp. 556–565, Aug. 2013, doi: 10.1111/cns.12127.
[22]
C. N. Serhan, ‘Resolution Phase of Inflammation: Novel Endogenous Anti-Inflammatory and Proresolving Lipid Mediators and Pathways’, Annual Review of Immunology, vol. 25, no. 1, pp. 101–137, Apr. 2007, doi: 10.1146/annurev.immunol.25.022106.141647.
